• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

利用常规和观测数据的记录链接,可以有效地获得针对特定人群和最新的心血管风险图表。

Population specific and up to date cardiovascular risk charts can be efficiently obtained with record linkage of routine and observational data.

机构信息

Institute of Social and Preventive Medicine ISPM, University of Zurich, Zurich, Switzerland.

出版信息

PLoS One. 2013;8(2):e56149. doi: 10.1371/journal.pone.0056149. Epub 2013 Feb 14.

DOI:10.1371/journal.pone.0056149
PMID:23457516
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3573036/
Abstract

BACKGROUND

Only few countries have cohorts enabling specific and up-to-date cardiovascular disease (CVD) risk estimation. Individual risk assessment based on study samples that differ too much from the target population could jeopardize the benefit of risk charts in general practice. Our aim was to provide up-to-date and valid CVD risk estimation for a Swiss population using a novel record linkage approach.

METHODS

Anonymous record linkage was used to follow-up (for mortality, until 2008) 9,853 men and women aged 25-74 years who participated in the Swiss MONICA (MONItoring of trends and determinants in CVD) study of 1983-92. The linkage success was 97.8%, loss to follow-up 1990-2000 was 4.7%. Based on the ESC SCORE methodology (Weibull regression), we used age, sex, blood pressure, smoking, and cholesterol to generate three models. We compared the 1) original SCORE model with a 2) recalibrated and a 3) new model using the Brier score (BS) and cross-validation.

RESULTS

Based on the cross-validated BS, the new model (BS = 14107×10(-6)) was somewhat more appropriate for risk estimation than the original (BS = 14190×10(-6)) and the recalibrated (BS = 14172×10(-6)) model. Particularly at younger age, derived absolute risks were consistently lower than those from the original and the recalibrated model which was mainly due to a smaller impact of total cholesterol.

CONCLUSION

Using record linkage of observational and routine data is an efficient procedure to obtain valid and up-to-date CVD risk estimates for a specific population.

摘要

背景

仅有少数国家拥有可用于特定且最新的心血管疾病(CVD)风险评估的队列。基于与目标人群差异过大的研究样本进行个体风险评估可能会危及风险图表在一般实践中的应用效果。我们的目的是使用新的记录链接方法为瑞士人群提供最新且有效的 CVD 风险评估。

方法

使用匿名记录链接来随访(截至 2008 年的死亡率)年龄在 25-74 岁之间的 9853 名男性和女性,他们参加了 1983-92 年的瑞士 MONICA(心血管疾病趋势和决定因素监测)研究。链接成功率为 97.8%,1990-2000 年的随访损失率为 4.7%。基于 ESC SCORE 方法(Weibull 回归),我们使用年龄、性别、血压、吸烟和胆固醇生成了三个模型。我们比较了 1)原始 SCORE 模型与 2)重新校准的模型和 3)使用 Brier 评分(BS)和交叉验证的新模型。

结果

基于交叉验证的 BS,新模型(BS=14107×10(-6))在风险估计方面比原始模型(BS=14190×10(-6))和重新校准的模型(BS=14172×10(-6))更为合适。特别是在较年轻的年龄,得出的绝对风险始终低于原始模型和重新校准的模型,这主要是由于总胆固醇的影响较小。

结论

使用观察性和常规数据的记录链接是为特定人群获得有效且最新的 CVD 风险估计的有效程序。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/41cd/3573036/abf1d2b4f277/pone.0056149.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/41cd/3573036/32a2fc9f2090/pone.0056149.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/41cd/3573036/abf1d2b4f277/pone.0056149.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/41cd/3573036/32a2fc9f2090/pone.0056149.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/41cd/3573036/abf1d2b4f277/pone.0056149.g002.jpg

相似文献

1
Population specific and up to date cardiovascular risk charts can be efficiently obtained with record linkage of routine and observational data.利用常规和观测数据的记录链接,可以有效地获得针对特定人群和最新的心血管风险图表。
PLoS One. 2013;8(2):e56149. doi: 10.1371/journal.pone.0056149. Epub 2013 Feb 14.
2
Blood glucose may be an alternative to cholesterol in CVD risk prediction charts.血糖可能是 CVD 风险预测图表中胆固醇的替代品。
Cardiovasc Diabetol. 2013 Jan 25;12:24. doi: 10.1186/1475-2840-12-24.
3
Establishing a follow-up of the Swiss MONICA participants (1984-1993): record linkage with census and mortality data.建立瑞士 MONICA 参与者(1984-1993 年)的随访:与人口普查和死亡率数据的记录链接。
BMC Public Health. 2010 Sep 21;10:562. doi: 10.1186/1471-2458-10-562.
4
Global cardiovascular mortality risk in the adult Polish population: prospective assessment of the cohorts studied in multicentre national WOBASZ and WOBASZ Senior studies.波兰成年人群的全球心血管疾病死亡风险:在多中心全国性WOBASZ和WOBASZ老年研究中对队列的前瞻性评估。
Kardiol Pol. 2016;74(3):262-73. doi: 10.5603/KP.a2015.0175. Epub 2015 Sep 14.
5
Better risk assessment with glycated hemoglobin instead of cholesterol in CVD risk prediction charts.糖化血红蛋白比胆固醇更能改善 CVD 风险预测图中的风险评估。
Eur J Epidemiol. 2013 Jul;28(7):551-5. doi: 10.1007/s10654-013-9827-6. Epub 2013 Jul 17.
6
Public health significance of four cardiovascular risk factors assessed 25 years ago in a low prevalence country.25 年前在一个低流行率国家评估的四项心血管危险因素的公共卫生意义。
Eur J Prev Cardiol. 2013 Feb;20(1):151-60. doi: 10.1177/1741826711430282. Epub 2011 Nov 11.
7
Laboratory-based and office-based risk scores and charts to predict 10-year risk of cardiovascular disease in 182 countries: a pooled analysis of prospective cohorts and health surveys.基于实验室和基于办公室的风险评分和图表,以预测 182 个国家 10 年内的心血管疾病风险:前瞻性队列研究和健康调查的汇总分析。
Lancet Diabetes Endocrinol. 2017 Mar;5(3):196-213. doi: 10.1016/S2213-8587(17)30015-3. Epub 2017 Jan 24.
8
Statistical modelling of 10-year fatal cardiovascular disease risk in Greece: the HellenicSCORE (a calibration of the ESC SCORE project).希腊10年心血管疾病致死风险的统计模型:希腊SCORE(欧洲心脏病学会SCORE项目的校准)
Hellenic J Cardiol. 2007 Mar-Apr;48(2):55-63.
9
The recalibrated HellenicSCORE based on newly derived risk factors from the Hellenic National Nutrition and Health Survey (HNNHS); the HellenicSCORE II.基于希腊国家营养与健康调查(HNNHS)中推导出的新风险因素重新校准的希腊斯堪的纳维亚心脏终点研究评分(HellenicSCORE);HellenicSCORE II。
Hellenic J Cardiol. 2021 Jul-Aug;62(4):285-290. doi: 10.1016/j.hjc.2020.03.006. Epub 2020 Apr 18.
10
Predictive accuracy and usefulness of calibration of the ESC SCORE in Switzerland.瑞士ESC评分的预测准确性及校准的有用性。
Eur J Cardiovasc Prev Rehabil. 2008 Aug;15(4):402-8. doi: 10.1097/HJR.0b013e3282fb040f.

引用本文的文献

1
2022 Saudi Guidelines for the Management of Dyslipidemia.《2022年沙特血脂异常管理指南》
Heart Views. 2023 Apr-Jun;24(2):67-92. doi: 10.4103/heartviews.heartviews_102_22. Epub 2023 Feb 24.

本文引用的文献

1
Health risk or resource? Gradual and independent association between self-rated health and mortality persists over 30 years.健康风险还是资源?自评健康与死亡率之间的逐渐和独立关联持续 30 多年。
PLoS One. 2012;7(2):e30795. doi: 10.1371/journal.pone.0030795. Epub 2012 Feb 9.
2
Public health significance of four cardiovascular risk factors assessed 25 years ago in a low prevalence country.25 年前在一个低流行率国家评估的四项心血管危险因素的公共卫生意义。
Eur J Prev Cardiol. 2013 Feb;20(1):151-60. doi: 10.1177/1741826711430282. Epub 2011 Nov 11.
3
National, regional, and global trends in body-mass index since 1980: systematic analysis of health examination surveys and epidemiological studies with 960 country-years and 9·1 million participants.
1980 年以来全球、区域和国家的体重指数趋势:对 960 个国家/地区年和 910 万人的健康检查调查和流行病学研究的系统分析。
Lancet. 2011 Feb 12;377(9765):557-67. doi: 10.1016/S0140-6736(10)62037-5. Epub 2011 Feb 3.
4
Establishing a follow-up of the Swiss MONICA participants (1984-1993): record linkage with census and mortality data.建立瑞士 MONICA 参与者(1984-1993 年)的随访:与人口普查和死亡率数据的记录链接。
BMC Public Health. 2010 Sep 21;10:562. doi: 10.1186/1471-2458-10-562.
5
Significant decrease in in-hospital mortality and major adverse cardiac events in Swiss STEMI patients between 2000 and December 2007.2000年至2007年12月期间,瑞士ST段抬高型心肌梗死患者的住院死亡率和主要不良心脏事件显著下降。
Swiss Med Wkly. 2009 Aug 8;139(31-32):453-7. doi: 10.4414/smw.2009.12607.
6
Culture, risk factors and mortality: can Switzerland add missing pieces to the European puzzle?文化、风险因素与死亡率:瑞士能否为欧洲的谜团添上缺失的部分?
J Epidemiol Community Health. 2009 Aug;63(8):639-45. doi: 10.1136/jech.2008.081042. Epub 2009 Apr 21.
7
Predictive accuracy and usefulness of calibration of the ESC SCORE in Switzerland.瑞士ESC评分的预测准确性及校准的有用性。
Eur J Cardiovasc Prev Rehabil. 2008 Aug;15(4):402-8. doi: 10.1097/HJR.0b013e3282fb040f.
8
Cohort Profile: the Swiss National Cohort--a longitudinal study of 6.8 million people.队列简介:瑞士国民队列——一项对680万人的纵向研究。
Int J Epidemiol. 2009 Apr;38(2):379-84. doi: 10.1093/ije/dyn042. Epub 2008 Mar 7.
9
European guidelines on cardiovascular disease prevention in clinical practice: full text. Fourth Joint Task Force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts).欧洲临床实践中心血管疾病预防指南:全文。欧洲心脏病学会及其他学会关于临床实践中心血管疾病预防的第四联合工作组(由九个学会的代表及特邀专家组成)。
Eur J Cardiovasc Prev Rehabil. 2007 Sep;14 Suppl 2:S1-113. doi: 10.1097/01.hjr.0000277983.23934.c9.
10
[Calibrating the SCORE cardiovascular risk chart for use in Spain].[校准用于西班牙的SCORE心血管风险图表]
Rev Esp Cardiol. 2007 May;60(5):476-85.